DLB Dolby Laboratories
- 82.630
- -0.310-0.37%
Dolby Laboratories News
Barrington Reaffirms Their Hold Rating on Dolby Laboratories (DLB)
Earnings Call Summary | Dolby Laboratories(DLB.US) Q2 2024 Earnings Conference
The following is a summary of the Dolby Laboratories, Inc. (DLB) Q2 2024 Earnings Call Transcript:Financial Performance:Dolby posted a Q2 revenue of $365 million, marking a 3% decrease compared to the
Q2 2024 Dolby Laboratories Inc Earnings Call
Dolby Laboratories Inc (DLB) Q2 2024 Earnings Call Transcript Highlights: Navigating Market ...
Dolby Laboratories Fiscal Q2 Adjusted Earnings Rise, Revenue Declines; Issues Fiscal Q3 Outlook
Dolby Laboratories (DLB) reported fiscal Q2 adjusted earnings late Thursday of $1.27 per diluted share, up from $1.26 a year earlier. Three analysts polled by Capital IQ expected $1.23. Total revenue
Research Alert: CFRA Maintains Hold Rating On Shares Of Dolby Laboratories, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our price target by $6 to $83,
Dolby Laboratories, Inc. (DLB) Q2 2024 Earnings Call Transcript
Dolby Laboratories, Inc. (DLB) Q2 2024 Earnings Call Transcript
Dolby Laboratories To Go Ex-Dividend On May 13th, 2024 With 0.3 USD Dividend Per Share
May 3rd - $Dolby Laboratories(DLB.US)$ is trading ex-dividend on May 13th, 2024. Shareholders of record on May 14th, 2024 will receive 0.3 USD dividend per share on May 22nd, 2024. The ex-dividend
Dolby Laboratories (DLB) Reports Q2 Earnings: What Key Metrics Have to Say
Dolby Laboratories Inc (DLB) Q2 2024 Earnings: Consistent With Analyst Projections
Dolby Laboratories (DLB.US): The 2024 Q2 financial report achieved revenue of US$364.5 million, prior value of US$375.9 million, expected value of US$359.4 million; earnings per share were US$1.27, previous value was US$1.26, and expected value was US$1.1
Dolby Laboratories (DLB.US): The 2024 Q2 financial report achieved revenue of US$364.5 million, prior value of US$375.9 million, expected value of US$359.4 million; earnings per share were US$1.27, previous value was US$1.26, and expected value was US$1.19.
Dolby Laboratories Q2 2024 Adj EPS $1.27 Beats $1.19 Estimate, Sales $364.523M Beat $359.442M Estimate
Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $1.19 by 6.72 percent. This is a 0.79 percent increase over earnings of $1.26
Earnings Flash (DLB) DOLBY LABORATORIES Reports Q2 Revenue $364.5M, Vs. Street Est of $359.4M
04:27 PM EDT, 05/02/2024 (MT Newswires) -- Earnings Flash (DLB) DOLBY LABORATORIES Reports Q2 Revenue $364.5M, vs. Street Est of $359.4M
Press Release: Dolby Laboratories Reports Second Quarter 2024 Financial Results
Dolby Laboratories Reports Second Quarter 2024 Financial Results PR Newswire SAN FRANCISCO, May 2, 2024 SAN FRANCISCO, May 2, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announce
Dolby Laboratories 2Q EPS $1.01 >DLB
Dolby Laboratories 2Q EPS $1.01 >DLB
Dolby Laboratories Is Maintained at Buy by Rosenblatt
Dolby Laboratories Is Maintained at Buy by Rosenblatt
Rosenblatt: Maintains Dolby Laboratories (DLB.US) rating, adjusted from buy to buy rating, and adjusted target price from $98.00 to $98.00.
Rosenblatt: Maintains Dolby Laboratories (DLB.US) rating, adjusted from buy to buy rating, and adjusted target price from $98.00 to $98.00.
Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target
Rosenblatt analyst Steve Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintains $98 price target.
Dolby Laboratories Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/29/2024 23.74% Rosenblatt $98 → $98 Maintains Buy 01/31/2024 23.74% Rosenblatt → $98 Reiterates Buy → B
Earnings Preview: DLB to Report Financial Results Post-market on May 02
$Dolby Laboratories(DLB.US)$ is scheduled to release its financial results post-market on May 02. Earnings PreviewAnalysts estimate $Dolby Laboratories(DLB.US)$ to post revenue of USD359.58 million fo
Analysis
Price Target
No Data
